Last reviewed · How we verify
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
The purpose of this study is to explore the effect of treating actinic keratoses of the face with imiquimod 3.75% cream followed by photodynamic therapy in comparison to treatment with imiquimod alone
Details
| Lead sponsor | Tennessee Clinical Research Center |
|---|---|
| Phase | Phase 4 |
| Status | TERMINATED |
| Enrolment | 21 |
| Start date | 2010-09 |
| Completion | 2011-11 |
Conditions
- Actinic Keratosis
Interventions
- Photodynamic therapy
- Imiquimod
Primary outcomes
- Actinic Keratosis Count — Week 18 (4 weeks after randomization visit)
The percent change in actinic keratosis count as compared to the baseline lesion count
Countries
United States